Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration

被引：3
|
作者：
Sullivan, Kathleen M. [1 ]
Dores, Graca M. [1 ]
Nayernama, Afrouz [1 ]
Prowell, Tatiana M. [2 ,3 ]
Pradhan, Shan M. [2 ]
Osgood, Christy [2 ]
Jones, S. Christopher [1 ]
机构：
[1] US FDA, Div Pharmacovigilance, Off Surveillance & Epidemiol, Ctr Drug Evaluat, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Off Oncol Dis, Ctr Drug Evaluat, Silver Spring, MD USA
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 10期
关键词：
D O I：
10.1001/jamaoncol.2022.3249
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1503 / 1505
页数：4
相关论文
共 50 条
  • [41] Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
    Joshua D. Wallach
    Anita T. Luxkaranayagam
    Sanket S. Dhruva
    Jennifer E. Miller
    Joseph S. Ross
    BMC Medicine, 17
  • [42] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019
    Wei, Shaokui
    Niu, Manette T.
    Dores, Graca M.
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 253 - 262
  • [43] Recalls of foods and cosmetics due to microbial contamination reported to the US Food and Drug Administration
    Wong, S
    Street, D
    Delgado, SI
    Klontz, KC
    JOURNAL OF FOOD PROTECTION, 2000, 63 (08) : 1113 - 1116
  • [44] Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products
    Kwa, Michael
    Welty, Leah J.
    Xu, Shuai
    JAMA INTERNAL MEDICINE, 2017, 177 (08) : 1202 - 1204
  • [45] Prescription medications for use in pregnancyeperspective from the US Food and Drug Administration
    Ren, Zhaoxia
    Bremer, Andrew A.
    Pawlyk, Aaron C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (01) : 33 - 42
  • [46] Dermatology-related postmarketing study commitments to the Food and Drug Administration
    Bognet, Rachel A.
    Chiang, David S.
    Katz, Kenneth A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 721 - 723
  • [47] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
  • [48] Urokinase and the US food and drug administration
    Ouriel, K
    JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
  • [49] Independence at the US Food and Drug Administration
    不详
    LANCET, 2006, 367 (9523): : 1630 - 1630
  • [50] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
12345